Amy Larkin is currently the Director and Clinical Research Scientist at Eli Lilly and Company, where they lead global clinical trials and serve as a scientific resource for clinical trial teams. With over 22 years of expertise in therapeutic clinical trial leadership and critical chain project management, Amy has been involved in a range of studies spanning various medical areas, including pediatrics. They earned a BS in Life Science from Indiana State University and obtained a Critical Chain Professional Certification in 2011. Amy has also received a Leadership Award for Diversity in 2009 for their contributions to fostering diverse talent within the corporate community.
This person is not in any teams
This person is not in any offices